Back
China SXT Pharmaceuticals Vs. Adagene Industry Stock Comparison
Sell
25
SXTC
China SXT Pharmaceuticals
Last Price:
0.43
Seasonality Move:
12.18%
Sell
30
ADAG
Adagene
Last Price:
2.27
Seasonality Move:
65.35%
Sell
25
China SXT Pharmaceuticals (SXTC)
is a Sell
Is China SXT Pharmaceuticals a Buy, Sell or Hold?
- The current China SXT Pharmaceuticals [SXTC] share price is $0.46. The Score for SXTC is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
- SXTC is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Adagene (ADAG)
is a Sell
Is Adagene a Buy, Sell or Hold?
- The current Adagene [ADAG] share price is $2.37. The Score for ADAG is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- ADAG is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SXTC Stock Price Chart
What is China SXT Pharmaceuticals's stock price today?
-
The China SXT Pharmaceuticals share price today is $0.46
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SXTC is experiencing slight selling pressure.
ADAG Stock Price Chart
SXTC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.05 | Sell |
| Relative Strength Index (14 RSI): | 35.81 | Sell |
| Chaikin Money Flow: | -23640 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.5 - 0.62) | Sell |
| Bollinger Bands (100): | (0.58 - 1.06) | Sell |
ADAG Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.01 | Buy |
| Relative Strength Index (14 RSI): | 38.75 | Sell |
| Chaikin Money Flow: | 17416 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.35 - 3.05) | Sell |
| Bollinger Bands (100): | (2.33 - 2.95) | Sell |
SXTC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.48 | Sell |
| 20-day SMA: | 0.55 | Sell |
| 50-day SMA: | 0.6 | Sell |
| 200-day SMA: | 1.15 | Sell |
| 8-day EMA: | 0.49 | Sell |
| 20-day EMA: | 0.54 | Sell |
| 50-day EMA: | 0.63 | Sell |
| 200-day EMA: | 2 | Sell |
ADAG Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.77 | Sell |
| 20-day SMA: | 2.83 | Sell |
| 50-day SMA: | 2.6 | Sell |
| 200-day SMA: | 2.75 | Sell |
| 8-day EMA: | 2.66 | Sell |
| 20-day EMA: | 2.72 | Sell |
| 50-day EMA: | 2.66 | Sell |
| 200-day EMA: | 2.57 | Sell |
China SXT Pharmaceuticals Earnings Growth & SXTC Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Adagene Earnings Growth & ADAG Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.94 per share, and a decrease next year of $0.09 per share.
China SXT Pharmaceuticals Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Adagene Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||